Neuromodulation trials

BEAT AF - Braking Ectopic Atrial Trends In Atrial Fibrillation

RecruitingNCT05872776Phase: NAStarted 2023-02-16

Summary

Paroxysmal AF subjects with a documented ECG event of AF will be recruited to the study To assess the efficacy of CardiaCare™ RR2 wearable home-care neuromodulation system in reducing AF burden and sy

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
85 Years

Locations

Tel Aviv Sourasky Medical CenterTel Aviv, Israel
Clalit Health Services (HMO)Tel Aviv, Israel

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT05872776